Modern injectable anti-inflammatory, nonsteroidal with analgesic and antipyretic action.
Pharmaceutical form: Injectable Solution.
Active substance: Flunixin Meglumine 5mg%.
Indications: Anti-inflammatory in acute and bacterial infections of the respiratory system as an adjunct to antimicrobial treatment.
Inflammation and pain associated with gastrointestinal disturbances (calf diarrhea, enteritis, salmonellosis, gastroenteritis, colic). Lameness, arthritis, paresis. Relief of visceral pain associated with the presence of colic. Syndrome of metritis mastitis agalaxia (MMA), in porcine.
Presentation: 50ml ampoule bottle.
Benefits: It has been perfectly proved that corticosteroid therapy is highly useful in the treatment of varied acute or chronic inflammatory conditions, especially those in the collagen tissue. The use of injectable corticosteroids of immediate and keeps the animal for longer time under the action of the medicine with a single injection dose. A wide spectrum of inflammatory conditions is covered thereby, ranging from serious affections to those appearing as a mild joint pain able to decrease, in a lower or higher degree, the animal’s performance.
Destination Species: Sport equines non destined to human food consumption.
Indications: Alergic or inflammatory conditions, localized or general. Neuritis, tendinitis, bursitis, arthritis, mialgias, anaphylactic and/or traumatic shock.
Posology: according to professional criterion, depending on the pathology to treat.
Intravenous, intramuscular, intraarticular, periarticular, Intrasinovial injection. Local infiltrations.
Interval Between Doses:
a) 24 hours for intravenous or intramuscular injection.
b) In local, intrasinovial, periarticular and intraarticular infiltrations, the dose shall
be repeated according to the professional criterion.
c) In case of anaphylactic shock, intravenous every 4 hours or according to
Presentation: 2 ml vial (40 mg of dexametasone 21 phosphate)
Formula: Dexametasone 21 fosfate……………. 2 g
Formulation agents q.s. ………………100 ml